Active Solicitation · DEPT OF DEFENSE

    SIR Y90 MICROSPHERES

    Sol. W81K0427QA001Sources SoughtFORT BELVOIR, VA
    Open · 12d remaining
    DAYS TO CLOSE
    12
    closes May 27, 2026
    POSTED
    May 15, 2026
    Publication date
    NAICS CODE
    334517
    Primary industry classification
    PSC CODE
    6515
    Product & service classification

    AI Summary

    The Department of Defense is seeking information for SIR-Spheres® Y-90 resin microspheres for treating unresectable metastatic liver tumors. This Sources Sought Notice is for planning purposes only, and responses are requested from interested vendors. The contract will be sole sourced to Sirtex Medical Inc. Interested parties should respond via email with company details.

    Contract details

    Solicitation No.
    W81K0427QA001
    Notice Type
    Sources Sought
    Posted Date
    May 15, 2026
    Response Deadline
    May 27, 2026
    NAICS Code
    334517AI guide
    PSC / Class Code
    6515
    Issuing Office
    W40M MRCO EAST
    Primary Contact
    Frank Fogg
    State
    VA
    ZIP Code
    22060-5580
    AI Product/Service
    product

    Description

    This is a Request for Information (RFI) – Sources Sought Notice Only. This notice is issued solely for information and planning purposes only.
     

     The US Government will not pay for any information or administrative costs incurred in response to this notice. Submittals will not be returned to the responder; not responding to this notice does not preclude participation in any further RFQ; IFB or RFP if issued.

    Health  Readiness Contracting Office -(HRCO), Womack Army Medical Center (WAMC), Fort Bragg, NC 28310, intends to solicit, negotiate, and award a sole sourced   contract to Sirtex Medical Inc. 300 Unicorn Park Drive Woburn, MA 01801, United States.   

    Sirtex Medical Inc will provide SIR-Spheres® Y-90 resin microspheres and other materials used in conjunction with the microspheres. SIR-Spheres® Y-90 resin microspheres are indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy (IHAC) of FUDR (Floxuridine). Additionally, there are no other companies or firms that sells or distribute such items. 

    The solicitation number is W91YTZ27QA0011, and the resulting award will be made on DD Form 1449 (Order for Commercial Items). This requirement is for commercial supply for the Department of Nuclear Medicine. The NAICS for this requirement is 334517- Irradiation Apparatus Manufacturing, and Product Service Code (PSC)- Q527 Medical- Nuclear Medicine. The point of contact for this requirement is Frank Fogg frank.a.fogg.civ@health.mil. The Contracting Officer is Amush Collins at anush.m.collins.civ@army.mil.

     Your email response shall provide the following:

    Can you provide supply the following supply:

    Sirtex Medical Inc will provide SIR-Spheres® Y-90 resin microspheres and other materials used in conjunction with the microspheres. SIR-Spheres® Y-90 resin microspheres are indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy (IHAC) of FUDR (Floxuridine). Additionally, there are no other companies or firms that sells or distribute such items. 

    If your company can offer this supply item please respond via e-mail to the POC with:


    Name of Company
    Point of contact
    Phone number
    Email address
    Identify Your Small Business Socio-Economic Group
    DUNS number and CAGE Code

    No telephonic inquiries will be responded to

    Key dates

    1. May 15, 2026Posted Date
    2. May 27, 2026Proposals / Responses Due

    AI search tags

    Frequently asked questions

    SIR Y90 MICROSPHERES is a federal acquisition solicitation issued by DEPT OF DEFENSE. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.